This is a competing renewal application for a Senior Scientist Award (K0-5) to continue research on the biological and behavioral aspects of substance abuse. The proposed research is based on several grant awards currently funded by NIDA, NIH. I am Principal Investigator on four awards: (1) a Program Project designed to evaluate new strategies for cocaine treatment medications in basic preclinical and clinical studies; (2) an R01 award for preclinical studies of the interactions between cocaine and opioid drugs with different receptor selectivities; (3) an R01 award to study the influence of gonadal steroid hormones on the reinforcing and discriminative stimulus effects of cocaine and (4) a contract concerned with the assessment of potential treatment medications in rhesus monkeys. In addition, I am co-investigator on an R01 award designed to evaluate the analgesic and abuse-related effects of delta opioids; an R01 award concerned with the synthesis and evaluation of mixed action kappa/mu opioids and a contract to assess potential cocaine treatment medications in rats. I am also co-investigator on a NIDA training grant and responsible for mentoring young scientists. Many of these multidisciplinary clinical and pre-clinical studies are concerned with the neurobiology of cocaine abuse from an endocrine perspective. The influence of gonadal steroid hormones on the reinforcing and discriminative stimulus effects of cocaine is being studied in non-human primates. The temporal pattern of cocaine's acute effects on anterior pituitary, gonadal and adrenal hormones is being examined in men and women, and in non-human primates. We hypothesize that the rapid co-modulatory interactions between cocaine and the hypothalamic-pituitary-gonadal and adrenal axes may contribute to cocaine's abuse-related effects and could suggest new approaches to treatment. The effects of mu, kappa and delta opioids on cocaine self-administration are being evaluated in preclinical behavioral pharmacology studies. In related studies, the effects of dopaminergic and opioid drug combinations on the abuse-related effects of cocaine and heroin """"""""speedballs"""""""" are being evaluated. We hypothesize that medication combinations will be more effective in decreasing """"""""speedball"""""""" abuse than single medications alone. Proposed plans for professional growth include continued study of endocrinology, brain imaging and computer science as well as study of two new directions in our research program that involve collaborative studies in medicinal chemistry and immunology.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Scientist Award (K05)
Project #
2K05DA000101-21
Application #
6731572
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Acri, Jane
Project Start
1984-01-01
Project End
2008-12-31
Budget Start
2004-03-01
Budget End
2004-12-31
Support Year
21
Fiscal Year
2004
Total Cost
$114,915
Indirect Cost
Name
Mc Lean Hospital (Belmont, MA)
Department
Type
DUNS #
046514535
City
Belmont
State
MA
Country
United States
Zip Code
02478
Eshleman, Amy J; Forster, Michael J; Wolfrum, Katherine M et al. (2014) Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function. Psychopharmacology (Berl) 231:875-88
Mello, Nancy K; Peltier, Mackenzie R; Duncanson, Haley (2013) Nicotine levels after IV nicotine and cigarette smoking in men. Exp Clin Psychopharmacol 21:188-95
Mello, Nancy K; Knudson, Inge M; Kelly, Maureen et al. (2011) Effects of progesterone and testosterone on cocaine self-administration and cocaine discrimination by female rhesus monkeys. Neuropsychopharmacology 36:2187-99
Vujanovic, Anka A; Marshall, Erin C; Gibson, Laura E et al. (2010) Cognitive-affective characteristics of smokers with and without posttraumatic stress disorder and panic psychopathology. Addict Behav 35:419-25
Mello, Nancy K (2010) Hormones, nicotine, and cocaine: clinical studies. Horm Behav 58:57-71
Marshall, Erin C; Johnson, Kirsten; Bergman, Jenna et al. (2009) Anxiety sensitivity and panic reactivity to bodily sensations: relation to quit-day (acute) nicotine withdrawal symptom severity among daily smokers making a self-guided quit attempt. Exp Clin Psychopharmacol 17:356-64
Goletiani, Nathalie V; Mendelson, Jack H; Sholar, Michelle B et al. (2009) Opioid and cocaine combined effect on cocaine-induced changes in HPA and HPG axes hormones in men. Pharmacol Biochem Behav 91:526-36
Marshall, Erin C; Vujanovic, Anka A; Kutz, Amanda et al. (2009) Reasons for quitting smoking prior to a self-quit attempt among smokers with and without posttraumatic stress disorder or other anxiety/mood psychopathology. Am J Addict 18:309-15
Negus, S S; Mello, N K; Kimmel, H L et al. (2009) Effects of the monoamine uptake inhibitors RTI-112 and RTI-113 on cocaine- and food-maintained responding in rhesus monkeys. Pharmacol Biochem Behav 91:333-8
Negus, S S; Baumann, M H; Rothman, R B et al. (2009) Selective suppression of cocaine- versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine. J Pharmacol Exp Ther 329:272-81

Showing the most recent 10 out of 78 publications